Verition Fund Management
APEN

Verition Fund Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Verition Fund Management’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-247,210
Closed -$2.45M – 2737
2023
Q1 		$2.45M Buy
247,210
+234,210
+1,802% +$2.32M 0.03% 631
2022
Q4 		$130K Buy
+13,000
New +$96.9K ﹤0.01% 1819

Verition Fund Management's APEN Position: Q2 2023 in Review

Verition Fund Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 247,210 shares — an estimated $2.45M sold.

Verition Fund Management first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $2.45M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Verition Fund Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Verition Fund Management sold 247,210 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $2.45M.
  • Verition Fund Management first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
  • Verition Fund Management's Apollo Endosurgery, Inc. position peaked at $2.45M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Verition Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.